PTC THERAPEUTICS, INC. — Director's Dealing 2021

Jan 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2021-01-06

Reporting Person: Reeve Emma (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-06	Common Stock	A	1650	—	Acquired	4328	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-06	Stock Option (Right To Buy)	$66.49	A	10000	Acquired	2031-01-05	Common Stock (10000.0)	Direct

Footnotes

F1: Restricted stock units ("RSUs") granted on January 6, 2021 that vest over one year, with five-twelfths (5/12) of the shares underlying the RSUs vesting on June 8, 2021 and the remaining seven-twelfths (7/12) of the original shares underlying the RSUs vesting on January 6, 2022.

F2: This option was granted on January 6, 2021 and vests over one year in twelve equal monthly installments, commencing on February 6, 2021.